Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FTC’s Latest Effort To Dispute Improper Patent Listings Barely Made A Dent
Only One Out Of 10 Addressed NDAs Had Its Patent Listing Updated
Jul 21 2025
•
By
Urtė Fultinavičiūtė
(Shutterstock)
More from Legal & IP
More from Generics Bulletin